Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Gardasill 9™ vaccine
United Therapeutics Europe Ltd
Neoplasia
1 trial -
Glycerin Suppository
United Therapeutics Europe Ltd
Encopresis
1 trial -
Home non-invasive ventilation
United Therapeutics Europe Ltd
Hypercapnic Respiratory Failure
1 trial -
Hormonal Contraception
United Therapeutics Europe Ltd
Pregnancy
1 trial -
Hormone replacement therapy (estrogen/progestin)
United Therapeutics Europe Ltd
Anorexia Nervosa
1 trial -
Household-based water treatment with NADCC tablets
United Therapeutics Europe Ltd
Diarrhoea
1 trial -
IL-1Ra
United Therapeutics Europe Ltd
Subarachnoid Hemorrhage
1 trial -
Imatinib
United Therapeutics Europe Ltd
Myeloid Leukemia, Chronic, Chronic Phase
1 trial -
Imiquimod
United Therapeutics Europe Ltd
Cervical Intraepithelial Neoplasia
1 trial -
Immunoglobulins, Intravenous (Privigen)
United Therapeutics Europe Ltd
Encephalitis
1 trial -
In-person Cognitive Behavioral Therapy of Insomnia
United Therapeutics Europe Ltd
Insomnia
1 trial -
Inhaled Treprostinil
United Therapeutics Europe Ltd
Idiopathic Pulmonary Fibrosis
1 trial -
Inhaled treprostinil
United Therapeutics Europe Ltd
Pulmonary Hypertension
5 trials -
Inhaled treprostinil solution
United Therapeutics Europe Ltd
Pulmonary Hypertension
2 trials -
Intervention - a validated home BP monitor and support from the specialist nurse
United Therapeutics Europe Ltd
Stroke
1 trial -
Iron (27 mg) - folic acid (600 ug)
United Therapeutics Europe Ltd
Infant Mortality
1 trial -
Isoniazid with Ethambutol
United Therapeutics Europe Ltd
Human Immunodeficiency Virus
1 trial -
KALOMIN™ Tab.
United Therapeutics Europe Ltd
Acute Bronchitis
1 trial -
Ketamine
United Therapeutics Europe Ltd
Chronic Pain
1 trial -
Ketamine Hydrochloride
United Therapeutics Europe Ltd
Traumatic Injury
1 trial -
Khalas dates
United Therapeutics Europe Ltd
Diabetes Mellitus
1 trial -
L-leucovorin
United Therapeutics Europe Ltd
Colorectal Cancer
1 trial -
LY2189265
United Therapeutics Europe Ltd
Diabetes Mellitus, Type 2
1 trial -
Lactobacillus plantarum
United Therapeutics Europe Ltd
Constipation - Functional
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources